NIH Study Validates Posit Science’s Brain Training in Dementia Prevention

Event summary

  • NIH-funded ACTIVE Study found 23 hours of Posit Science’s speed-of-processing training reduced Alzheimer’s risk by 25% over 20 years.
  • Posit Science’s BrainHQ app, featuring the Double Decision exercise, was central to the study’s findings.
  • INHANCE Study in October 2025 showed BrainHQ training upregulates acetylcholine, a key brain chemical declining with dementia.
  • BrainHQ is available in 13 languages, with subscriptions at $96/year, and has been validated in over 300 studies.

The big picture

The ACTIVE Study’s findings reinforce the growing recognition of brain plasticity as a modifiable factor in dementia prevention, aligning with broader trends in personalized medicine and digital therapeutics. Posit Science’s long-standing research pipeline positions it as a key player in a market increasingly focused on proactive cognitive health management. The validation of acetylcholine upregulation adds a biochemical layer to the company’s value proposition, potentially expanding its appeal to both consumers and healthcare providers.

What we're watching

Market Adoption
The pace at which health plans and medical centers integrate BrainHQ into preventive care protocols.
Competitive Positioning
Whether Posit Science can sustain differentiation as more digital health players enter the brain training space.
Regulatory Validation
How the NIH-backed study results influence reimbursement policies for cognitive training interventions.